• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Methyl 4-Bromoquinoline-8-carboxylate (CAS No. 132664-48-3): An Overview of Its Properties, Applications, and Recent Research

Methyl 4-bromoquinoline-8-carboxylate (CAS No. 132664-48-3) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique molecular structure, which includes a quinoline core and a bromo substituent, making it an intriguing candidate for various applications, particularly in the development of novel therapeutic agents.

The chemical formula of methyl 4-bromoquinoline-8-carboxylate is C₁₂H₉BrNO₂, and it has a molecular weight of approximately 279.10 g/mol. The compound is a white to off-white crystalline solid at room temperature and is soluble in common organic solvents such as dichloromethane, ethanol, and dimethyl sulfoxide (DMSO). These solubility properties make it suitable for use in various synthetic reactions and biological assays.

In recent years, the study of methyl 4-bromoquinoline-8-carboxylate has been driven by its potential as an intermediate in the synthesis of more complex molecules with therapeutic value. Quinoline derivatives, in general, have been extensively investigated for their diverse biological activities, including antimalarial, anticancer, and anti-inflammatory properties. The presence of the bromo substituent on the quinoline ring can significantly influence the compound's reactivity and biological activity, making it a valuable scaffold for drug discovery.

One of the key areas of research involving methyl 4-bromoquinoline-8-carboxylate is its role as a building block in the synthesis of novel antimalarial agents. Malaria remains a significant global health challenge, and the development of new drugs with improved efficacy and reduced resistance is crucial. Studies have shown that quinoline-based compounds can effectively inhibit the growth of Plasmodium falciparum, the parasite responsible for the most severe form of malaria. The bromo substituent in methyl 4-bromoquinoline-8-carboxylate can be further modified to enhance its antimalarial activity through rational drug design.

Beyond antimalarial applications, methyl 4-bromoquinoline-8-carboxylate has also shown promise in cancer research. Quinoline derivatives have been found to exhibit cytotoxic effects against various cancer cell lines, including those resistant to conventional chemotherapy. The bromo substituent can be used to fine-tune the compound's selectivity and potency against cancer cells. Recent studies have explored the use of methyl 4-bromoquinoline-8-carboxylate as a starting material for synthesizing compounds that target specific signaling pathways involved in cancer progression.

In addition to its therapeutic potential, methyl 4-bromoquinoline-8-carboxylate has been utilized in the development of fluorescent probes for cellular imaging. The quinoline core provides a strong fluorescence signal, which can be further enhanced by modifying the substituents on the ring. These probes are valuable tools for studying cellular processes and can be used to monitor drug delivery and uptake in living cells.

The synthetic accessibility of methyl 4-bromoquinoline-8-carboxylate is another factor contributing to its widespread use in research. Several efficient synthetic routes have been developed to produce this compound on both laboratory and industrial scales. One common method involves the bromination of quinoline followed by esterification with methanol. These synthetic methods are well-documented in the literature and can be adapted to produce high-purity material suitable for various applications.

The safety profile of methyl 4-bromoquinoline-8-carboxylate is an important consideration for its use in pharmaceutical research. While it is generally considered safe when handled properly, appropriate precautions should be taken to avoid exposure to skin or inhalation. Safety data sheets (SDS) are available for reference, providing detailed information on handling, storage, and disposal procedures.

In conclusion, methyl 4-bromoquinoline-8-carboxylate (CAS No. 132664-48-3) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and versatile synthetic properties make it an attractive candidate for developing novel therapeutic agents with diverse applications. Ongoing research continues to uncover new possibilities for this compound, highlighting its importance in advancing our understanding of complex biological systems and developing innovative treatments for various diseases.

• 868656-97-7(Methyl 6-bromo-1H-indole-3-carboxylate)
• 1445781-45-2(Methyl 5-bromoquinoline-8-carboxylate)
• 928839-62-7(5-Bromoquinoline-8-carboxylic acid)
• 1416438-47-5(5-bromoquinoline-3-carboxylic acid)
• 1226762-74-8(Ethyl 7-bromoquinoline-3-carboxylate)
• 101909-43-7(Methyl 4-bromo-1H-indole-3-carboxylate)
• 481054-89-1(Ethyl 6-bromoquinoline-3-carboxylate)
• 860624-89-1(Methyl 5-bromo-1H-indole-7-carboxylate)
• 1383551-36-7(ethyl 5-bromoquinoline-3-carboxylate)
• 1416438-29-3(4-bromoquinoline-8-carboxylic acid)